The early data generated by pseudovirus testing of the full Omicron variant spike against the combination used in Evusheld provides preclinical evidence that it retains neutralizing activity against all tested variants of concern.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3m995HG
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Astrazeneca's Evusheld retains neutralizing activity against Omicron
https://ift.tt/eA8V8J
No comments:
Post a Comment